Bayesian Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bayesian Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,153	Closed	-$356K	–	610
2021 Q2	$356K	Buy	+2,153	New	+$359K	0.09%	237
2019 Q1	–	Sell	-4,949	Closed	-$455K	–	824
2018 Q4	$455K	Buy	+4,949	New	+$501K	0.09%	302
2017 Q4	–	Sell	-18,795	Closed	-$1.43M	–	780
2017 Q3	$1.43M	Buy	+18,795	New	+$1.42M	0.34%	83
2016 Q2	–	Sell	-4,825	Closed	-$206K	–	590
2016 Q1	$206K	Buy	+4,825	New	+$204K	0.19%	267

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Bayesian Capital Management's PRAH Position: Q3 2021 in Review

Bayesian Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,153 shares — an estimated $356K sold.

Bayesian Capital Management first reported a position in PRAH in Q1 2016 and held it in 4 quarters. The position peaked at $1.43M in Q3 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Bayesian Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Bayesian Capital Management sold 2,153 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $356K.
Bayesian Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 4 quarters.
Bayesian Capital Management's PRA Health Sciences, Inc. position peaked at $1.43M in Q3 2017.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Bayesian Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.